| Company Name: |
Wuhan Chemstan Biotechnology Co., Ltd. Gold
|
| Tel: |
027-65317797 15926423062 |
| Email: |
422450190@qq.com |
| Products Intro: |
Product Name:Ticilimumab
CAS:745013-59-6
Purity:>95% Package:100ug;200ug;1mg
|
| Company Name: |
Wuhan Sunrise Technology Development Co., Ltd.
|
| Tel: |
27-027-83314682 13554138826 |
| Email: |
whsrtech@vip.163.com |
| Products Intro: |
Product Name:Ticilimumab
CAS:745013-59-6
Purity:97% Package:5mg, 10mg, 20mg, 50mg, 100mg Remarks:only be used for R&D purpose
|
Tremelimumab manufacturers
- Tremelimumab
-
- $155.00
-
2026-05-21
- CAS:745013-59-6
- Purity: 95.00%
- Supply Ability: 10g
|
| | Tremelimumab Basic information |
| Product Name: | Tremelimumab | | Synonyms: | ticilimumab tremelimumab;Ticilimumab;Tremelimumab;Research Grade Tremelimumab (DHD17203);Research Grade Ticilimumab (DHD17204);Tremelimumab (anti-CTLA-4);Ticilimumab|||CP-675206 | | CAS: | 745013-59-6 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![Tremelimumab Structure]() |
| | Tremelimumab Chemical Properties |
| storage temp. | Store at -20°C | | form | Liquid | | color | Colorless to light yellow |
| | Tremelimumab Usage And Synthesis |
| Uses | Tremelimumab (Ticilimumab) is a fully human monoclonal antibody specific for cytotoxic T-lymphocyte antigen-4 (CTLA-4) and can be used for metastatic melanoma research[1]. | | References | [1] Comin-Anduix B, et al. Tremelimumab: research and clinical development. Onco Targets Ther. 2016 Mar 23;9:1767-76. DOI:10.2147/OTT.S65802 |
| | Tremelimumab Preparation Products And Raw materials |
|